Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

PANACEA BIOTEC LTD. - 531349 - Closure of Trading Window

 Pursuant to the Company''s Code of Conduct for Prevention of Insider Trading framed in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended from time to time, we would like to inform that the trading window of the Company shall remain closed for all the Designated Persons of the Company from April 01, 2021 till completion of 48 hours from the announcement to the Stock Exchanges regarding audited financial results of the Company for the financial year ended March 31, 2021. The date of meeting of the Board of Directors to approve the audited financial results of the Company for the financial year ended March 31, 2021, shall be informed in due course. This is for your kind information and record please.
31-03-2021
Bigul

PANACEA BIOTEC LTD. - 531349 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 This is with reference to CDSL's Operating Instructions for Issuers/RTAs, which states that the Issuer/RTA shall inform the details of the securities dematerialized to all the Stock Exchanges where the securities are listed. Accordingly, we are enclosing herewith the data of shares dematerialized during the month of February, 2021
06-03-2021
Bigul

PANACEA BIOTEC LTD. - 531349 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.

 The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on February 02, 2021 for Dr. Rajesh Jain, Soshil Kumar Jain & Sandeep Jain
02-03-2021
Bigul

PANACEA BIOTEC LTD. - 531349 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to bring to your kind notice that one of the shareholder has reported to the Company about loss of his Share Certificate and have requested for issuance of duplicate Share Certificate in lieu of the lost Share Certificate. The aforesaid request is under review and the said duplicate share certificate shall be issued only upon receipt of complete documents from the shareholder including completion of procedural requirements in this regard. This is for your kind information and record please.
26-02-2021
Bigul

PANACEA BIOTEC LTD. - 531349 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 In continuation to our letter dated February 12, 2021 for approving the Standalone and Consolidated Unaudited Financial Results (Provisional) for the quarter and nine months ended December 31, 2020 and pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith newspaper copies of Extract of Statement of aforesaid Unaudited Financial Results, published in the following newspapers on February 13, 2021:- ? Business Standard (English); ? Desh Sewak (Punjabi)
14-02-2021
Bigul

PANACEA BIOTEC LTD. - 531349 - Outcome Of The Board Meeting

 Pursuant to Regulations 30 and 33 of SEBI LODR Regulations, we would like to inform you that the Board of Directors of the Company has, at its meeting held today, i.e. February 12, 2021, inter-alia, considered and approved the Unaudited Standalone and Consolidated Financial Results (Provisional) of the Company (which have been subjected to Limited Review by the Statutory Auditors) for the quarter and nine months ended December 31, 2020. The same were also reviewed by the Audit Committee in its meeting held earlier on February 12, 2021. Further, pursuant to Regulation 47(1)(b) of SEBI LODR Regulations, the Extract of Statement of above said financial results for the quarter and nine months ended December 31, 2020 in the Format as prescribed in Annexure I of SEBI Circular No. CIR/CFD/FAC/62/2016 dated 05.07.2016 is being sent for publication in newspapers. The meeting of the Board of Directors commenced at 02:00 P.M. and concluded at 05:10 P.M
12-02-2021
Bigul

PANACEA BIOTEC LTD. - 531349 - Standalone And Consolidated Unaudited Financial Results (Provisional) Along With Limited Review Report For The Quarter And Nine Months Ended December 31, 2020

 Pursuant to Regulations 30 and 33 of SEBI LODR Regulations, we would like to inform you that the Board of Directors of the Company has, at its meeting held today, i.e. February 12, 2021, inter-alia, considered and approved the Unaudited Standalone and Consolidated Financial Results (Provisional) of the Company (which have been subjected to Limited Review by the Statutory Auditors) for the quarter and nine months ended December 31, 2020. The same were also reviewed by the Audit Committee in its meeting held earlier on February 12, 2021. Further, pursuant to Regulation 47(1)(b) of SEBI LODR Regulations, the Extract of Statement of above said financial results for the quarter and nine months ended December 31, 2020 in the Format as prescribed in Annexure I of SEBI Circular No. CIR/CFD/FAC/62/2016 dated 05.07.2016 is being sent for publication in newspapers. The meeting of the Board of Directors commenced at 02:00 P.M. and concluded at 05:10 P.M
12-02-2021
Bigul

PANACEA BIOTEC LTD. - 531349 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 This is with reference to CDSL's Operating Instructions for Issuers/RTAs, which states that the Issuer/RTA shall inform the details of the securities dematerialized to all the Stock Exchanges where the securities are listed. Accordingly, we are enclosing herewith the data of shares dematerialized during the month of January, 2021
06-02-2021
Bigul

PANACEA BIOTEC LTD. - 531349 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 In continuation to our letter dated February 03, 2021 intimating the date of proposed Board Meeting scheduled to be held on February 12, 2021, for approving the Standalone and Consolidated Unaudited Financial Results (Provisional) for the quarter and nine months ended December 31,2020 and pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith newspaper copies of the notice of Board Meeting published in the following newspapers on February 04, 2021:- Business Standard (English); Desh Sewak (Punjabi)
05-02-2021
Bigul

PANACEA BIOTEC LTD. - 531349 - Board Meeting Intimation for Approving The Standalone And Consolidated Unaudited Financial Results (Provisional) For The Quarter And Nine Months Ended December 31, 2020

 PANACEA BIOTEC LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2021 ,inter alia, to consider and approve Pursuant to Regulation 29 of SEBI LODR Regulations, this is to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Friday, February 12, 2021 at New Delhi, inter-alia, to consider and approve the Standalone and Consolidated Unaudited Financial Results (Provisional) for the quarter and nine months ended December 31, 2020 Further, with reference to our earlier announcement dated December 31, 2020 intimating the Closure of Trading Window pursuant to the Company's Code of Conduct for Prevention of Insider Trading framed in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended from time to time, we would like to inform that the trading window of the Company shall remain closed for all the Designated Persons of the Company and Material Subsidiaries of the Company till February 14, 2021.
03-02-2021
Next Page
Close

Let's Open Free Demat Account